ERBB2 and ovarian carcinoma: Importantly, ACE1702, cryopreserved irradiated ACE-oNK-HER2, significantly suppressed HER2-expressing tumor burden in an ovarian cancer xenograft model, while HER2 expression of the remaining tumor mass in ACE1702-treated mice is worthy of further study (Figure 6).